About Glutamine synthetase
Glutamine synthetase (GLUL) is a protein
from Homo sapiens identified by UniProt accession
P15104, 373 residues long.
MolForge cross-references it against 0 known binders and
361 disease associations.
Target properties
| Protein name | Glutamine synthetase |
| UniProt accession | P15104 |
| Gene | GLUL |
| Organism | Homo sapiens |
| Length | 373 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (2)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (361)
Diseases linked to this target (Open Targets).
- congenital brain dysgenesis due to glutamine synthetase deficiency · score 0.77
- neurodegenerative disease · score 0.52
- developmental and epileptic encephalopathy · score 0.49
- progressive myoclonic epilepsy with dystonia · score 0.49
- malignant migrating partial seizures of infancy · score 0.49
- Seizure · score 0.37
- Red cell distribution width · score 0.33
- high density lipoprotein cholesterol measurement · score 0.22
- lymphocyte count · score 0.21
- leukocyte count · score 0.20
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P15104-F1 | alphafold | PREDICTED | 97.53 | — |
Amino-acid sequence (373 residues)
MTTSASSHLN KGIKQVYMSL PQGEKVQAMY IWIDGTGEGL RCKTRTLDSE PKCVEELPEW NFDGSSTLQS EGSNSDMYLV PAAMFRDPFR KDPNKLVLCE VFKYNRRPAE TNLRHTCKRI MDMVSNQHPW FGMEQEYTLM GTDGHPFGWP SNGFPGPQGP YYCGVGADRA YGRDIVEAHY RACLYAGVKI AGTNAEVMPA QWEFQIGPCE GISMGDHLWV ARFILHRVCE DFGVIATFDP KPIPGNWNGA GCHTNFSTKA MREENGLKYI EEAIEKLSKR HQYHIRAYDP KGGLDNARRL TGFHETSNIN DFSAGVANRS ASIRIPRTVG QEKKGYFEDR RPSANCDPFS VTEALIRTCL LNETGDEPFQ YKN
Explore Glutamine synthetase with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets